CinDome Pharma
Business Services · Ohio, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
5375 Medpace Way, Cincinnati, Ohio, 4522...Phone Number
(513) 579-9911Website
www.cindome.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About CinDome Pharma
CinDome Pharma, a CinRx portfolio company, is focused on developing deudomperidone (CIN-102) for the treatment of chronic gastroparesis, a condition affecting millions in the U.S. The company aims to provide a safe and effective long-term therapy for patients suffering from this debilitating condition, which currently lacks adequate treatment options. Deudomperidone is designed to improve gastric emptying and alleviate symptoms of nausea and vomiting associated with gastroparesis. CinDome is actively enrolling patients for clinical trials targeting both idiopathic and diabetic gastroparesis.Explore more
Popular SearchesCindome Pharma IncCinDomeCindome PharmaSIC Code 87,873NAICS Code 54,541Show more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is CinDome Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if CinDome Pharma has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when CinDome Pharma launches new products
Congratulate Masked Content for being promoted to Masked Content at CinDome Pharma
Earning: See what the market has to say on CinDome Pharma recently announced quarterly report
Website visits: Recent activity has been detected on your website
Check out if CinDome Pharma is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once CinDome Pharma has new funding data
CinDome Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if CinDome Pharma had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined CinDome Pharma as Masked Content
Find 3 more new buyers
Compare Similar Companies to CinDome Pharma
Compare insights from companies similar to CinDome Pharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
CinDome Pharma
<$5M
11-50
Private
$59M
2019
N/A
Company Profile Activity
Activity Insights
CinDome Pharma is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
CinDome Pharma is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about CinDome Pharma.
CinDome Pharma financials insights
Gather financial insights about CinDome Pharma, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2024
Series B
$59M
CinDome Pharma Tech Stack
A closer look at the technologies used by CinDome Pharma
See more technologies
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Funding
Funding
Event
Events
Event
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding CinDome Pharma
Sign Up For FreeTo access detailed company insights
CinDome Pharma, a CinRx portfolio company, is focused on developing deudomperidone (CIN-102) for the treatment of chronic gastroparesis, a condition affecting millions in the U.S. The company aims to provide a safe and effective long-term therapy for patients suffering from this debilitating condition, which currently lacks adequate treatment optio... Read More
